|
(R)-(+)-冰片胺
|
R469087-500mg
|
≥97% |
32511-34-5 |
500mg
|
¥ 389.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1R,2R)-(+)-N,N′-二甲基-1,2 -双[3-(三氟甲基)苯基]乙二胺
|
R468718-100mg
|
≥97% |
137944-39-9 |
100mg
|
¥ 188.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(R)-(+)-1,2-环氧-9-癸烯
|
R468715-100mg
|
≥97% |
137310-67-9 |
100mg
|
¥ 1105.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(R)-2-{双[3,5-双(三氟甲基)苯基]甲基}吡咯烷盐酸盐
|
R468635-500mg
|
≥97% |
1217463-08-5 |
500mg
|
¥ 2025.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2R,5R)-(+)-5-乙烯基-2-奎宁环甲醇
|
R468248-250mg
|
≥96% |
N/A |
250mg
|
¥ 507.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
R-(叔-丁基甲基膦基-二-叔-丁基膦甲烷)-η₄-(1,5-环辛二烯)四氟硼酸铑(I)
|
R468246-100mg
|
≥96% |
N/A |
100mg
|
¥ 330.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(R)-5,5-二甲基-6-苯基-3,4,5,6-四氢嘧啶
|
R468244-100mg
|
≥96% |
N/A |
100mg
|
¥ 330.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(R)-N-[(1R,2R)-2-(3-(3) ,5-双(三氟甲基)苯基)脲基)环己基]-叔丁基-亚磺酰胺
|
R468227-500mg
|
≥96% |
934762-68-2 |
500mg
|
¥ 4318.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(R)-N-[(1R,2R)-2-(3-(3) ,5-双(三氟甲基)苯基)脲基)环己基]-叔丁基-亚磺酰胺
|
R468227-100mg
|
≥96% |
934762-68-2 |
100mg
|
¥ 1796.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2R,5R)-(+)-5-苄基-3-甲基-2-(5-甲基-2-呋喃基)-4-咪唑烷酮
|
R468212-500mg
|
≥96% |
877303-84-9 |
500mg
|
¥ 2599.9
|
现货 |
|
0 |
阿拉丁 |
|
(2R,5R)-(+)-5-苄基-3-甲基-2-(5-甲基-2-呋喃基)-4-咪唑烷酮
|
R468212-250mg
|
≥96% |
877303-84-9 |
250mg
|
¥ 1479.9
|
现货 |
|
0 |
阿拉丁 |
|
(2R,5R)-(+)-5-苄基-3-甲基-2-(5-甲基-2-呋喃基)-4-咪唑烷酮
|
R468212-100mg
|
≥96% |
877303-84-9 |
100mg
|
¥ 606.9
|
现货 |
|
0 |
阿拉丁 |
|
(R)-3,3'-双(三苯基硅基)-1,1'-联-2-萘酚
|
R468054-100mg
|
≥98% |
111822-69-6 |
100mg
|
¥ 246.9
|
现货 |
|
0 |
阿拉丁 |
|
(1R,2R)-1,2-双(2-羟基苯基)乙二胺
|
R468017-100mg
|
≥95%(HPLC) |
870991-70-1 |
100mg
|
¥ 238.9
|
现货 |
|
0 |
阿拉丁 |
|
(R)-2-(甲氧基二苯基甲基)吡咯烷
|
R468006-500mg
|
≥95%(HPLC) |
948595-05-9 |
500mg
|
¥ 4764.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(R)-2-(甲氧基二苯基甲基)吡咯烷
|
R468006-100mg
|
≥95%(HPLC) |
948595-05-9 |
100mg
|
¥ 1480.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
[Ru(bpz)₃][PF₆]₂
|
R467962-50mg
|
≥95% |
80907-56-8 |
50mg
|
¥ 160.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
[Ru(bpz)₃][PF₆]₂
|
R467962-100mg
|
≥95% |
80907-56-8 |
100mg
|
¥ 240.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(R)-1-Boc-3-氟吡咯烷
|
R467547-500mg
|
≥95% |
N/A |
500mg
|
¥ 588.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(R)-1-Fmoc-3-羟基哌啶
|
R467542-500mg
|
≥95% |
N/A |
500mg
|
¥ 333.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(R)-TolBINAP Pd G4
|
R467522-250mg
|
≥95% |
N/A |
250mg
|
¥ 274.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1R,4R,8R)-5-苄基-2-异丁基-8-甲氧基-1,8-二甲基双环[ 2.2.2]八-2,5-二烯
|
R467477-100mg
|
≥95% |
948594-95-4 |
100mg
|
¥ 2720.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(R)-3-氨基-5-己炔酸盐酸盐
|
R467243-250mg
|
≥95% |
332064-87-6 |
250mg
|
¥ 1831.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
RuPhos Pd G1 甲基t-丁基醚加合物
|
R467210-250mg
|
≥95% |
2361069-97-6 |
250mg
|
¥ 748.9
|
期货,请咨询 |
|
0 |
阿拉丁 |